Takuji Hanamura

Title: Takuji Hanamura: Innovator in Lyophilization Technology

Introduction

Takuji Hanamura is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the method of lyophilizing cold insoluble globulin. His innovative approach has implications for the stability and usability of pharmaceutical preparations.

Latest Patents

Hanamura holds a patent for a method of lyophilizing cold insoluble globulin. This patent describes a process that allows for the preparation of a lyophilized cold insoluble globulin in a stable condition and in a short time. The method involves lyophilizing an aqueous solution of cold insoluble globulin in the presence of albumin and a neutral amino acid, a monosaccharide, a disaccharide, or a sugar alcohol. The resulting preparation dissolves in water without turbidity and is suitable for injection.

Career Highlights

Takuji Hanamura is associated with The Green Cross Corporation, where he applies his expertise in biopharmaceutical development. His work has contributed to advancements in the formulation of injectable medications, enhancing their stability and effectiveness.

Collaborations

Hanamura has collaborated with notable colleagues, including Akimasa Ohmizu and Yutaka Hirao. These collaborations have fostered innovation and development in their respective fields.

Conclusion

Takuji Hanamura's contributions to lyophilization technology exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and work at The Green Cross Corporation highlight the importance of stability in drug formulations.